Skip to main content

Table 3 Biomarker level during acute phase in patients with central and peripheral vertigo

From: Serum miRNA125a-5p, miR-125b-5p, and miR-433-5p as biomarkers to differentiate between posterior circulation stroke and peripheral vertigo

miRNA level [median (IQR)]

Central Vertigo (n = 23)

Peripheral Vertigo (n = 35)

P value

miR-125a-5p

568.7 (338.2–924.5)

244.5 (160.8–495.1)

0.001*

miR-125b-5p

125.0 (98.01–199.8)

48.6 (22.66–103.7)

< 0.001*

miR-143-3p

321.6 (188.7–407.2)

172.5 (102.2–242.2)

0.014*

miR-342-3p

44.8 (16.39–118.7)

37.76 (14.57–136.4)

0.81

miR-376a-3p

134.3 (78.07–209.5)

87.93 (56.63–167.6)

0.056

miR-433-5p

92.13 (49.06–183.2)

53.45 (35.37–102.3)

0.006*

  1. *P < 0.05